This is an ad by BetterHelp. Did I talk too much? I should have handled that better. Why can't I just let it go? Why did I do that? I wish I would stop overthinking so much. Oh, why did I do that? Take a breath. You're not alone. Let's talk about what's going on. Counseling helps you sort through the noise with qualified professionals. An online therapy makes it convenient. See if it's for you.

Visit betterhelp.com forward slash random podcast for 10% off your first month of online therapy.

This podcast is sponsored by Tradeu. Here's something of interest, a multi-asset trading platform that lets you earn 4.5% on your stock account cash balance.

It's made possible with today's sponsor, Tradeu, where you can trade with an institutional edge.

Get access to global markets, institutional grade pricing, and no hidden fees.

Traydu, your trade, your move.

Explore more at tradeu.com. Your capital is at risk, interest, subject to minimum balance,

terms and conditions apply.

Hello and welcome to the intelligence from the economist. From London today, I'm John Fastman.

Every weekday, we provide a fresh perspective on the events shaping your world.

India's pharmaceutical sector produces one-fifth of the world's generic drug supply,

thanks to rock-bottom prices.

But concerns about quality control and corner-cutting continue to beset the industry.

And in 2020 and 2021, one single story dominated the world's news.

Here's a hint.

It concerned a contagious virus with a spike protein.

What was the dominant story in 2022?

Keep listening, and you'll find out.

But first. This week, a court in Iran sentenced Faisah Hashmi, a women's rights activist, to five years in prison.

Daughter of the former Iranian president, Akbar Hashmi Rastanjani, she was convicted of propaganda

against the system, a crime dreamt up by the ideologues of Tehran.

That's just one of a number of high-profile prosecutions.

...